Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07403084
Recruiting Not applicable

Post-market Clinical Follow-up Study of NEMOST V2

NCT07403084 · tracked via the Priya Life Science France tracker
Sponsor
EUROS
Phase
Not applicable
Started
2025-12-19
Last updated
2026-02-11

Condition(s) studied

Scoliosis NeuromuscularScoliosis IdiopathicConsent Forms

Investigational drug(s) / intervention(s)

NEMOST V2 growing domino

NEMOST V2 growing domino: The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.

Study summary

The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.

As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.

Retrospective and prospective multicenter post-market surveillance clinical study.

This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.

The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.

The study will include 140 patients.

Eligibility

Sex
ALL
Min age
5 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention. * The patient, as well as their parents or legal guardians, are informed of the participation in the study. * Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth Exclusion Criteria: * signs of local inflammation; * acute or chronic, local or systemic infections ; * non-reducible scoliosis ; * pathological obesity ; * allergy or intolerance to implanted materials; * insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Hopital Lenval Nice Nice Provence-Alpes-Côte d'Azur Region Recruiting
CHU Pellegrin Bordeaux France Recruiting
Hospices Civils de Lyon Lyon France Not Yet Recruiting
Hopital Armand Trousseau Paris France Not Yet Recruiting
Hopital Necker Paris France Not Yet Recruiting

More EUROS trials in France

Post Market Clinical Follow-up of EUROSTEM Femoral Stem Active, not recruiting
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE Active, not recruiting
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup Active, not recruiting

Other trials for the same condition

Paravertebral Muscles Assessment Using High-resolution MRI in Idiopathic or Neuromuscular Scoliosis Children Recruiting
Spinal Bracing in Adults With Painful Degenerative Scoliosis: a Randomized Controlled Open Trial Starting soon
Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07403084 on ClinicalTrials.gov ↗ ← All trials in France